Involvement of serum vascular endothelial growth factor family members in the development of obesity in mice and humans

Journal of Nutritional Biochemistry

Volumn 21, Issue 8, 2010, Pages 774-780

  Gómez Ambrosi, Javier ^a,b   Catalán, Victoria ^a,b   Rodríguez, Amaia ^a,b   Ramírez, Beatriz ^a,b   Silva, Camilo ^a,b   Gil, María J ^a,b   Salvador, Javier ^a,b   Frühbeck, Gema ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Adipose tissue; High fat diet; Leptin; Ob ob mice; Obesity; VEGF

Indexed keywords

LEPTIN; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D;

ADIPOSE TISSUE; ADULT; ANIMAL EXPERIMENT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HORMONE SUBSTITUTION; HUMAN; LEAN BODY WEIGHT; MALE; MOUSE; NONHUMAN; OBESITY; ROUX Y ANASTOMOSIS; STOMACH BYPASS; VASCULARIZATION; WEIGHT REDUCTION;

ANIMALS; BODY MASS INDEX; DIETARY FATS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEPTIN; MALE; MICE; OBESITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE; MUS;

EID: 77954660746     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.05.004     Document Type: Article

References (44)

1. Frühbeck G. Overview of adipose tissue and its role in obesity and metabolic disorders. Methods Mol Biol 2008, 456:1-22.
2. Bray G.A., Wilson J.F. In the clinic. Obesity. Ann Intern Med 2008, 149. ITC4-1-15.
3. Gómez-Ambrosi J., Frühbeck G. Unlocking the molecular basis of obesity. Future Lipidol 2007, 2:577-581.
4. Gómez-Ambrosi J., Catalán V., Diez-Caballero A., Martínez-Cruz L.A., Gil M.J., García-Foncillas J., et al. Gene expression profile of omental adipose tissue in human obesity. FASEB J 2004, 18:215-217.
5. Rupnick M.A., Panigrahy D., Zhang C.Y., Dallabrida S.M., Lowell B.B., Langer R., et al. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A 2002, 99:10730-10735.
6. Cao Y. Angiogenesis modulates adipogenesis and obesity. J Clin Invest 2007, 117:2362-2368.
7. Lijnen H.R. Angiogenesis and obesity. Cardiovasc Res 2008, 78:286-293.
8. Nishimura S., Manabe I., Nagasaki M., Hosoya Y., Yamashita H., Fujita H., et al. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes 2007, 56:1517-1526.
9. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9:669-676.
10. Roy H., Bhardwaj S., Ylä-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 2006, 580:2879-2887.
11. Lazarovici P., Marcinkiewicz C., Lelkes P.I. Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development. Curr Pharm Des 2006, 12:2609-2622.
12. Ylä-Herttuala S., Rissanen T.T., Vajanto I., Hartikainen J. Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol 2007, 49:1015-1026.
13. Voros G., Maquoi E., Demeulemeester D., Clerx N., Collen D., Lijnen H.R. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology 2005, 146:4545-4554.
14. Miyazawa-Hoshimoto S., Takahashi K., Bujo H., Hashimoto N., Yagui K., Saito Y. Roles of degree of fat deposition and its localization on VEGF expression in adipocytes. Am J Physiol Endocrinol Metab 2005, 288:E1128-E1136.
15. Lijnen H.R., Van Hoef B., Kemp D., Collen D. Inhibition of vascular endothelial growth factor receptor tyrosine kinases impairs adipose tissue development in mouse models of obesity. Biochim Biophys Acta 2007, 1770:1369-1373.
16. Miyazawa-Hoshimoto S., Takahashi K., Bujo H., Hashimoto N., Saito Y. Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia 2003, 46:1483-1488.
17. Ledoux S., Queguiner I., Msika S., Calderari S., Rufat P., Gasc J.M., et al. Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity. Diabetes 2008, 57:3247-3257.
18. Das S.K., Roberts S.B., Kehayias J.J., Wang J., Hsu L.K., Shikora S.A., et al. Body composition assessment in extreme obesity and after massive weight loss induced by gastric bypass surgery. Am J Physiol Endocrinol Metab 2003, 284:E1080-E1088.
19. Ginde S.R., Geliebter A., Rubiano F., Silva A.M., Wang J., Heshka S., et al. Air displacement plethysmography: validation in overweight and obese subjects. Obes Res 2005, 13:1232-1237.
20. Das S.K. Body composition measurement in severe obesity. Curr Opin Clin Nutr Metab Care 2005, 8:602-606.
21. Gómez-Ambrosi J., Salvador J., Rotellar F., Silva C., Catalán V., Rodríguez A., et al. Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass. Obes Surg 2006, 16:262-269.
22. Gómez-Ambrosi J., Salvador J., Silva C., Pastor C., Rotellar F., Gil M.J., et al. Increased cardiovascular risk markers in obesity are associated with body adiposity: role of leptin. Thromb Haemost 2006, 95:991-996.
23. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
24. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410.
25. Hausman G.J., Richardson R.L. Adipose tissue angiogenesis. J Anim Sci 2004, 82:925-934.
26. Seida A., Wada J., Kunitomi M., Tsuchiyama Y., Miyatake N., Fujii M., et al. Serum bFGF levels are reduced in Japanese overweight men and restored by a 6-month exercise education. Int J Obes Relat Metab Disord 2003, 27:1325-1331.
27. Silha J.V., Krsek M., Sucharda P., Murphy L.J. Angiogenic factors are elevated in overweight and obese individuals. Int J Obes 2005, 29:1308-1314.
28. Rehman J., Considine R.V., Bovenkerk J.E., Li J., Slavens C.A., Jones R.M., et al. Obesity is associated with increased levels of circulating hepatocyte growth factor. J Am Coll Cardiol 2003, 41:1408-1413.
29. Baranova A., Collantes R., Gowder S.J., Elariny H., Schlauch K., Younoszai A., et al. Obesity-related differential gene expression in the visceral adipose tissue. Obes Surg 2005, 15:758-765.
30. Harvey N.L. The link between lymphatic function and adipose biology. Ann N Y Acad Sci 2008, 1131:82-88.
31. Lijnen H.R., Frederix L., Van Hoef B., Dewerchin M. Deficiency of vascular endothelial growth factor-D does not affect murine adipose tissue development. Biochem Biophys Res Commun 2009, 378:255-258.
32. Fukumura D., Ushiyama A., Duda D.G., Xu L., Tam J., Krishna V., et al. Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res 2003, 93:e88-e97.
33. Claffey K.P., Wilkison W.O., Spiegelman B.M. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J Biol Chem 1992, 267:16317-16322.
34. Tang W., Zeve D., Suh J.M., Bosnakovski D., Kyba M., Hammer R.E., et al. White fat progenitor cells reside in the adipose vasculature. Science 2008, 322:583-586.
35. García de la Torre N., Rubio M.A., Bordiú E., Cabrerizo L., Aparicio E., Hernández C., et al. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin. J Clin Endocrinol Metab 2008, 93:4276-4281.
36. Kawamura T., Murakami K., Bujo H., Unoki H., Jiang M., Nakayama T., et al. Matrix metalloproteinase-3 enhances the free fatty acids-induced VEGF expression in adipocytes through toll-like receptor 2. Exp Biol Med 2008, 233:1213-1221.
37. Yang B., Lin P., Carrick K.M., McNulty J.A., Clifton L.G., Winegar D.A., et al. PPARγ agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats. Biochem Biophys Res Commun 2005, 334:176-182.
38. Fain J.N., Madan A.K., Hiler M.L., Cheema P., Bahouth S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004, 145:2273-2282.
39. Ye J., Gao Z., Yin J., He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 2007, 293:E1118-E1128.
40. Monacci W.T., Merrill M.J., Oldfield E.H. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 1993, 264:C995-C1002.
41. Maharaj A.S., Saint-Geniez M., Maldonado A.E., D'Amore P.A. Vascular endothelial growth factor localization in the adult. Am J Pathol 2006, 168:639-648.
42. Cao R., Brakenhielm E., Wahlestedt C., Thyberg J., Cao Y. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A 2001, 98:6390-6395.
43. Mick G.J., Wang X., McCormick K. White adipocyte vascular endothelial growth factor: regulation by insulin. Endocrinology 2002, 143:948-953.
44. Fain J.N., Madan A.K. Insulin enhances vascular endothelial growth factor, interleukin-8, and plasminogen activator inhibitor 1 but not interleukin-6 release by human adipocytes. Metabolism 2005, 54:220-226.